Loading...
XSHE
300501
Market cap432mUSD
Dec 05, Last price  
16.17CNY
1D
1.63%
1Q
-10.51%
Jan 2017
-55.92%
IPO
31.43%
Name

Shanghai Haishun New Pharmaceutical Packaging Co Ltd

Chart & Performance

D1W1MN
XSHE:300501 chart
P/E
41.03
P/S
2.68
EPS
0.39
Div Yield, %
0.93%
Shrs. gr., 5y
3.73%
Rev. gr., 5y
12.97%
Revenues
1.14b
+11.92%
149,003,104210,237,307277,366,830289,849,722293,978,431301,275,888375,617,177507,195,935621,030,370713,784,961856,857,7951,012,601,2351,020,872,0061,142,549,822
Net income
75m
-12.70%
19,791,06734,058,14244,466,12454,224,08958,767,41464,603,52165,811,23266,165,09666,976,219102,903,824104,645,765102,461,49185,441,74174,589,975
CFO
161m
+60.35%
026,495,96528,403,10462,805,42553,274,73033,462,32055,089,70327,489,66795,878,08277,485,971139,639,384136,957,656100,596,590161,307,846
Dividend
May 28, 20240.15 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. manufactures, sells, and exports primarily pharmaceutical packaging films in China and internationally. It offers cold-forming aluminum foils, PVC/Aclar high barrier thermoformable films, tropical blister foils, lidding foils for PTP blisters, AL/PE suppository laminates, child-resistant packaging, complex laminated flexible films, AL/PE strip packs, and PVC/PVDC transparent films under the HiPack brand name. The company is headquartered in Shanghai, China.
IPO date
Feb 04, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT